Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
about
Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patientsVitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirinInnate immune response of human alveolar macrophages during influenza A infectionInnate immune response to influenza A virus in differentiated human alveolar type II cellsData-Driven Modeling for Precision Medicine in Pediatric Acute Liver Failure.Virus-related liver cirrhosis: molecular basis and therapeutic options.Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients.Crosstalk between HIV and hepatitis C virus during co-infectionDetection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness.Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.The role of CXCR3 in the induction of primary biliary cirrhosis.Clinical use of CCR5 inhibitors in HIV and beyondDanoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection.Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinomaVitamin D improves viral response in hepatitis C genotype 2-3 naïve patients.Cytokines and HCV-related disorders.Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis C.High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activityIncreased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.Potential evidence for biotype-specific chemokine profile following BVDV infection of bovine macrophages.Analysis of serum inflammatory mediators identifies unique dynamic networks associated with death and spontaneous survival in pediatric acute liver failure.A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients.Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.Adaptive immune response during hepatitis C virus infection.Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses.CCL5: a double-edged sword in host defense against the hepatitis C virus.Multi-step regulation of interferon induction by hepatitis C virus.Inflammation and liver tumorigenesis.The role of chemokines in acute and chronic hepatitis C infection.Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan.Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4.Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma.The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta-analysis of randomised controlled trials.Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis.Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B.A discrete population of IFN λ-expressing BDCA3hi dendritic cells is present in human thymus.
P2860
Q24624237-5E419A15-AF7F-4795-B01B-19C2B67096DAQ26784321-9B217A29-85B2-4B81-84A1-E400534CC0D2Q28731580-825714B7-336A-4AC9-B126-B09F44AF9DCBQ30398629-8D62B55D-0FAB-49B9-BC2F-4E74C9729831Q31145534-A9DDE59D-EE95-48C0-ACBC-46F20A192674Q33718267-2F3665B1-5059-4A66-BB63-7517671EEF8FQ33912466-09D93591-1744-4D90-B58D-5478A4DD979EQ34218972-52B82D86-F396-4DE0-A2D5-2E7132AEEBA3Q34477691-1C694D81-05E7-49C6-BD3F-C426C829C6BBQ34673075-EB53E5C5-8D65-428D-BC9A-31AC9E2A8248Q35008551-6028D551-0DB4-417A-93BF-03E0811428ACQ35018145-BD75339E-BB08-412E-ABA2-DDF0B2F0B8D9Q35065912-7D4973E4-6964-4D3E-9DED-478DAAA1B994Q35563500-DF815EB0-FBCF-427E-80BC-8546DA5E259DQ35744895-299FF8E8-5E45-4AD4-871D-442071ED4BC6Q35776126-45F04DB7-A7EC-448A-94D8-1A314F321E70Q35960209-8234519D-4F56-47AF-9D9D-D731BE1C5BCDQ36172970-443512C2-6E2C-49D6-8D82-0681BE1AD77FQ36554751-591AD5E4-B7D5-4016-8F52-360ACC60205CQ36810593-78125C61-1D5E-4349-B7DA-2D12A9B2582EQ37187338-263F0BC5-952B-426A-B983-E692748CBE74Q37297602-D141651C-4993-4F8D-A5A4-EFA195CCB118Q37424353-68C77A36-63F8-43F0-914B-E5E62C36E3C5Q37668003-33FDF10A-E1F6-4102-AC61-33DF92053FBDQ37682489-2F8CB7D9-C2AF-44EE-963A-EE622F1EE2F7Q37696017-20227070-8E38-4395-AD40-F9764F45FD6DQ37952808-F57EF0D5-F352-4325-AB78-7E945372E3B7Q38071909-400C0DA0-8C06-4851-83F7-4EABF6ADB1F7Q38107461-3F059AA6-3D1F-470D-A437-87618F9E22C3Q38129709-27D21C90-AB14-4562-B4F2-97FBDF34E7D9Q38235254-903317F5-0302-4BF2-956F-69BB5C3CD823Q38892515-FAA5B16F-4BCA-4AEF-B622-57A6FD1AF763Q39366642-F343C3A6-E0E2-4E53-9171-D2BAE3F6ED12Q39450438-39DBFDA3-1E5A-4B0A-904A-92E1A1464E66Q40025978-FA37750C-9982-4E19-BE61-2029A860CB32Q40043487-26B0D8DD-CB06-4EF1-A0EC-D06B2D619A7DQ40073734-02EAC5CE-28AE-4B43-BFC6-14C3B31DD3D4Q40484068-575DE391-B3E8-4446-A98E-E4BD9F9EDA09Q41157144-15F68D88-E109-40ED-9C4E-E8AD206C08B9Q41441925-F1A7000B-DA00-4A3B-989E-8E016990920F
P2860
Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Role of chemokines and their r ...... ic hepatitis C virus infection
@ast
Role of chemokines and their r ...... ic hepatitis C virus infection
@en
Role of chemokines and their r ...... ic hepatitis C virus infection
@nl
type
label
Role of chemokines and their r ...... ic hepatitis C virus infection
@ast
Role of chemokines and their r ...... ic hepatitis C virus infection
@en
Role of chemokines and their r ...... ic hepatitis C virus infection
@nl
prefLabel
Role of chemokines and their r ...... ic hepatitis C virus infection
@ast
Role of chemokines and their r ...... ic hepatitis C virus infection
@en
Role of chemokines and their r ...... ic hepatitis C virus infection
@nl
P2093
P2860
P3181
P356
P1476
Role of chemokines and their r ...... ic hepatitis C virus infection
@en
P2093
Eduardo Sanz-de-Villalobos
Juan R Larrubia
Miryam Calvino
Selma Benito-Martínez
Trinidad Parra-Cid
P2860
P304
P3181
P356
10.3748/WJG.14.7149
P407
P577
2008-12-21T00:00:00Z